High expression of the PAX3-FKHR oncoprotein is required to promote tumorigenesis of human myoblasts
about
Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcomaCarnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR-dependent motility in alveolar rhabdomyosarcoma cellsThe PAX3-FOXO1 fusion protein present in rhabdomyosarcoma interferes with normal FOXO activity and the TGF-β pathway.New Treatments for Rhabdomyosarcoma: the Importance of Target PracticeGenomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children's Oncology Group.Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesisSmall molecule inhibition of PAX3-FOXO1 through AKT activation suppresses malignant phenotypes of alveolar rhabdomyosarcomaPAX3-FKHR regulates the expression of pleiotrophin to mediate motility in alveolar rhabdomyosarcoma cells.A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma.Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.FOXO transcription factors in cancer development and therapy.JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma.PAX3 in neuroblastoma: oncogenic potential, chemosensitivity and signalling pathways.Molecular diagnostics in the management of rhabdomyosarcoma.PAX3-FOXO1 and FGFR4 in alveolar rhabdomyosarcoma.FOXO Signaling Pathways as Therapeutic Targets in Cancer.Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma.PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma.
P2860
Q31121475-6304FD82-BEEA-4492-9520-36CC053B0311Q34245749-011DF56B-D0C5-44CF-94F5-B7EEE4F7AA2AQ35586103-DA33A791-9A03-4360-9E7A-067E4FBE8342Q35729362-C446D489-F31C-4973-A3D0-E51D2C569F24Q35947244-0C233B73-E3D7-448E-B390-0538BB8A076BQ36588372-014F5D52-C34A-4DD5-BE0A-2BB5C0254FF4Q37381276-C93DE6D8-6719-4B18-B6B8-CF36718A8297Q37384314-8B92E3BA-69F3-4591-9738-EDE80E2784B8Q38083828-EA962885-7AC6-49E9-A6DE-AF8D3D5A88C4Q38489532-BB58DDBA-CABC-402D-8524-CC102008ACF2Q38674456-B207D857-9F51-4D47-9DC5-2CDE7FFCC0BEQ38688601-D2DC8788-8F59-405F-9BC5-78BFC746E0DAQ38718679-2D176E67-899D-4799-BEC2-03B2937A0DE4Q39067308-C233B2FB-4C08-4D62-9559-3565A4D7E21DQ39069676-4E7E399C-52EF-49E3-9CFB-BD2A4D1ED1AAQ39481211-19AD479F-63CD-4D4D-95DE-70A5B683728BQ41377055-19DD50F5-20F2-445E-AB0D-A1FC17285C65Q42243558-81920A22-B3B4-4974-AD79-DA995B846662Q54977242-A7A7575A-0CBA-4453-A5D7-D3A6DDC14E90
P2860
High expression of the PAX3-FKHR oncoprotein is required to promote tumorigenesis of human myoblasts
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
High expression of the PAX3-FK ...... morigenesis of human myoblasts
@en
High expression of the PAX3-FK ...... origenesis of human myoblasts.
@nl
type
label
High expression of the PAX3-FK ...... morigenesis of human myoblasts
@en
High expression of the PAX3-FK ...... origenesis of human myoblasts.
@nl
prefLabel
High expression of the PAX3-FK ...... morigenesis of human myoblasts
@en
High expression of the PAX3-FK ...... origenesis of human myoblasts.
@nl
P2093
P2860
P1476
High expression of the PAX3-FK ...... morigenesis of human myoblasts
@en
P2093
Bruce R Pawel
Chune Zhang
Dara D Holder
Frederic G Barr
Shujuan J Xia
P2860
P304
P356
10.2353/AJPATH.2009.090192
P407
P577
2009-11-05T00:00:00Z